免疫检查点调控急性髓系白血病干细胞
急性髓系白血病干细胞(LSCs)表达MHC I类和II类分子及多种免疫检查点配体和受体,类似专职抗原提呈细胞,并位于骨髓免疫微环境中。免疫检查点抑制剂在AML疗效有限,但多种免疫检查点可直接信号调控LSCs自我更新、分化和扩增,其表达或可溶性形式常与更差生存相关。本文综述免疫球蛋白超家族和肿瘤坏死因子受体超家族中部分免疫检查点调控LSCs的证据,并探讨其作为新治疗靶点的可能。
要点
- LSCs表达MHC I/II类及多种免疫检查点配体/受体,类似专职抗原提呈细胞。
- 多种免疫检查点可直接信号调控AML原始细胞和LSCs的自我更新、分化与扩增。
- 免疫检查点细胞表面或可溶性形式表达常与更差生存相关,可能成为新治疗靶点。
核心结论
- 多种免疫球蛋白超家族和肿瘤坏死因子受体超家族免疫检查点独立于免疫调控作用直接调控LSCs,可能成为新治疗靶点。
研究设计与样本
- 综述,总结免疫球蛋白超家族和肿瘤坏死因子受体超家族中部分免疫检查点调控LSCs的近期数据。
主要发现
- LSCs表达MHC I类和II类分子及多种免疫检查点配体和受体,类似专职抗原提呈细胞。
- LSCs位于骨髓这一初级和次级淋巴器官中,周围有免疫细胞。
- 免疫检查点抑制剂在实体瘤中已成为标准治疗,但在AML中疗效非常有限。
- 多种免疫检查点可直接信号调控AML原始细胞和LSCs的自我更新、分化和扩增。
- 免疫检查点细胞表面或可溶性形式表达常与更差生存相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukemia stem cells (LSCs) express major histocompatibility complex (MHC) class I and II and many different immune checkpoint ligands and receptors, in which respect they resemble professional antigen-presenting cells. In addition, LSCs reside in the bone marrow (BM), a primary and secondary lymphoid organ, surrounded by immune cells. The function of these immune checkpoints (ICs) in the regulation of an anti-tumor immune response is well studied and IC inhibitors (ICIs) became a standard of care in many solid tumors. However, ICIs have very limited efficacy in AML. Nevertheless, the expression especially of immune activating ligands and receptors on LSCs is somewhat unexpected, since these cells have to evade protective immunity. Many ICs have been shown to mediate direct signaling in AML blasts and LSCs and thereby regulate self-renewal, differentiation and expansion of leukemic cells. Thus, the expression of ICs on the cell surface or their soluble forms often correlate with worse survival. In this review we summarize recent data on selected ICs of the immunoglobulin superfamily (IgSF) and the tumor necrosis factor receptor superfamily (TNFRSF) that have a documented role in the regulation of LSCs, independent of their immune regulatory role, and might become novel therapeutic targets.
引用
- Reinhardt C, Ochsenbein AF. Immune checkpoints regulate acute myeloid leukemia stem cells. Leukemia. 2025. PMID: 40175626. doi:10.1038/s41375-025-02566-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。